OncoQuest Pharmaceuticals Inc (078590) — Cash Flow Quality Index
OncoQuest Pharmaceuticals Inc (078590) has a Cash Flow Quality Index of -0.21x as of June 2025. Operating cash flow of ₩-303.65 Million is below net income of ₩1.46 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can OncoQuest Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
OncoQuest Pharmaceuticals Inc Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for OncoQuest Pharmaceuticals Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of OncoQuest Pharmaceuticals Inc.
Annual Cash Flow Quality Index for OncoQuest Pharmaceuticals Inc (2014–2024)
Year-by-year earnings quality comparison for OncoQuest Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.86x | ₩3.96 Billion | ₩4.60 Billion | ▼ -36.8% |
| 2023 | 1.36x | ₩11.19 Billion | ₩8.20 Billion | ▲ +5704.1% |
| 2022 | -0.02x | ₩-236.91 Million | ₩9.73 Billion | ▼ -101.3% |
| 2017 | 1.84x | ₩4.79 Billion | ₩2.60 Billion | ▲ +29.9% |
| 2016 | 1.42x | ₩3.54 Billion | ₩2.49 Billion | ▼ -32.9% |
| 2015 | 2.12x | ₩2.79 Billion | ₩1.32 Billion | ▲ +40.9% |
| 2014 | 1.50x | ₩1.02 Billion | ₩675.61 Million | — |